Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $6.26 Analyst target: $3.00 Upside: -52.08%
Trinity Biotech plc acquires, develops, manufactures and markets medical diagnostic products for the clinical laboratory and point of care (POC) segments of the diagnostic market in the United States, Africa, Asia and Europe. The company is headquartered in Bray, Ireland.
See the full interactive analysis & chart →Informational only — not investment advice.